Working closely with users and therapists, EPFL spin-off Emovo Care has developed a light and easy-to-attach hand exoskeleton for people unable to grasp objects following a stroke or accident. The device has been successfully ...
May 11, 2022
0
18
To many, tuberculosis (TB) may seem like a disease from a bygone era. But it still claims more than one million lives every year. And the problem is growing worse as Mycobacterium tuberculosis, the pathogen that causes TB, ...
May 9, 2022
0
86
Regulations that strengthened the nutritional requirements for school lunches were associated with a decline in signs of obesity among free or reduced-price lunch participating school children in kindergarten through 5th ...
May 5, 2022
0
3
For thousands of years, silk has been treasured for its qualities as a beautiful material for elegant garments. But scientists are harnessing the less obvious qualities of silk to develop versatile replacement parts for human ...
May 3, 2022
0
4
For neonates undergoing endotracheal intubation, nasal high-flow therapy improves the likelihood of successful intubation on the first attempt, according to a study published in the April 28 issue of the New England Journal ...
Apr 28, 2022
0
17
Peanut allergy can be deadly, and evidence shows that it affects nearly 2% of people in some Western countries. While the standard treatment for peanut allergy is to avoid exposure, oral immunotherapy is a heavily debated ...
Apr 26, 2022
0
5
According to new research, about one third of people who had a large vessel (severe) ischemic stroke, treated with mechanical clot removal, resumed work three months after stroke treatment. However, women were about half ...
Apr 21, 2022
0
11
If you have an eating disorder, it's important to know the treatment options, Mayo Clinic experts say.
Apr 19, 2022
0
12
On Wednesday, 5-year-old Mary Stegmueller will reach a major milestone. She will have outlived her predicted life expectancy. Twice.
Apr 11, 2022
0
57
A new type of immunotherapy making use of the immune system's "natural killer cells" could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial suggest.
Apr 11, 2022
0
147
